Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$60.33
neg -0.84
-1.37%
Today's Range: 60.07 - 61.08 | MRK Avg Daily Volume: 11,431,400
Last Update: 01/19/17 - 4:01 PM EST
Volume: 11,284,985
YTD Performance: 3.91%
Open: $61.08
Previous Close: $61.17
52 Week Range: $47.97 - $65.46
Oustanding Shares: 2,757,137,517
Market Cap: 169,508,814,545
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 8 8 6
Moderate Buy 1 0 0 0
Hold 3 6 6 7
Moderate Sell 1 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.68 1.86 1.86 2.08
Latest Dividend: 0.47
Latest Dividend Yield: 3.06%
Dividend Ex-Date: 12/13/16
Price Earnings Ratio: 31.37
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
31.37 31.50 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.48% 19.61% 17.75%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.50 -0.20 -0.06
Net Income -62.60 -0.30 -0.11
EPS -61.70 -0.20 -0.08
Earnings for MRK:
EBITDA 13.92B
Revenue 39.50B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $0.88 $0.93 $3.77 $3.83
Number of Analysts 9 2 10 10
High Estimate $0.93 $0.93 $3.82 $3.98
Low Estimate $0.84 $0.93 $3.72 $3.68
Prior Year $0.93 $0.89 $3.59 $3.77
Growth Rate (Year over Year) -5.38% 4.49% 4.93% 1.59%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The U.S. dollar weakened. The price of crude oil rose by about two bits to $51.40. Gold fell by $8 to $1,203. I am buyer, to replace the half position I sold soon. Ag commodities: wheat down $0.08, corn up $0.02, soybean down $0.05 and oats up $0.01. Lumber was flat. For the second day in a row bonds got schmeissed iShares Barclays 20+ Yr Treas.Bond ETF (TLT) down over a beaner, again. (Good sale in fixed income last week!) The 10-year bond yield rose by 7 basis points to 2.46%. The long bond yield rose by 5 basis points. The 2s/10s expanded by 4 basis points to about 124 basis points. Municipals got hit and so did closed-end muni-bond funds. High yield was junky - but Blackstone / GSO Strategic Credit Fund (BGB) rose by a penny. Banks continue to be sold for a second day in a row -- despite much higher bond yields and lower bond prices. Crickets from financial bulls -- who seem to rationalize the large move this week and lack of correlation to bonds as a random act. Our "Trade of the Week" (short C) is now down by 5.5% or $3 since the trade was discussed in my Diary. Retail remains for sale. But my view is that a sentiment extreme is developing. Insurance stocks got whacked, including fav Hartford Financial (HIG) . Brokerages got hit, too. Goldman Sachs (GS) , put on Best Ideas List last week at $242, is down to $231. Biotech was lower, but not materially so (Celgene (CELG) , Allergan (AGN) lower). Hwwever, spec biotech roiled to the downside (Intrexon (XON) , Ziopharm Oncology (ZIOP) , Acadia Pharmaceuticals (ACAD) , Aerie Pharmaceuticals (AERI) ). Autos mixed. Ford (F) up, General Motors (GM) down. Good for our
Bullish
Jan 12, 2017 | 7:21 AM EST
MRK was upgraded from Neutral to Overweight, Piper Jaffray said. $72 price target. Expect conditional approval for Keytruda by May.
Bullish
Jan 12, 2017 | 7:06 AM EST
MRK was upgraded from Equal-weight to Overweight, Morgan Stanley said. $71 price target. Expect that immuno-oncology can accelerate gro...
He's never really been a stock market guy anyway.
The terror that the futures struck, rightly or wrongly, has disappeared.

My Takeaways and Observations Real Money Pro($)

"I don't feel Tuesday...Tuesday has no feel." --
Animal health and oncology deal activity is heating up in 2017.

My Takeaways and Observations Real Money Pro($)

The U.S. dollar weakened -- now for about three days in a row. Crude oil dropped by $2.06 to under $52 a barrel. Gold rose by $11. Ag commodities: wheat up $0.04, corn up $0.15, soybeans up $0.10 and oats down $0.02. Lumber down $6.60. Bonds rallied, with yields about 4 basis points lower. The 2s/10s spread contracted by 2 basis points. Municipals were well bid (closed-end muni-bond funds were quite strong), along with taxables. Junk bonds were flat in price and yield. Blackstone/GSO Strategic Credit Fund (BGB) rose by another $0.04. Banks held firm, but brokerages and life insurance was lower. Autos unchanged. Energy got whacked with a two-beaner drop in oil. Old tech was mixed. But, Best Ideas short IBM (IBM)   tumbled by nearly $2 a share. Ag equipment -- the object of my disaffection -- were lower with both Deere (DE) and Caterpillar (CAT) weak. Jim "El Capitan" Cramer highlighted the bullish case for Caterpillar today.  Retail continues to be a land mine. Big pharma rallied led by Merck (MRK) and Eli Lilly (LLY) . Biotech was stronger -- plus 2% led by Allergan (AGN) (again!) and thanks to a high-profile M&A deal. Consumer staples suffered from Coca-Cola (KO) and Procter & Gamble (PG) research downgrades. I added to Campbell Soup (CPB) , however. (T)FANG, again popular -- continued so but far less than the strong Thursday-Friday period from last week. Here are some value-added contributions on our site today: 1. My dachshunds were partial to Jim "E l Capitan" Cramer's column that highlighted the pet/vet business. 2. Ben "Godlfinger" Cross on confidence. 3. Jeremy Lakosh on the
You have to think that if these stocks were so high once, then it's likely they will be again.
Potential acquirers include Gilead Sciences, Johnson & Johnson, Pfizer, Merck and Novartis.

Columnist Conversations

EMN put in its third straight monthly high last week.
FIBOCALL: CSX CSX gap opening higher today, based on news. Our overshoot level @ 41.92 and I need to see a c...
Market is little changed as we are on the cusp of a presidential turnover.  Oil up a bit and seems to hav...
join me after the day of trading for a webinar talking about volume, how to analyze it and when to take it ser...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.